Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Gummesson

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|April 19, 2017
Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetesAnders Gummesson, Elisabeth Nyman, Mikael Knutsson, et al.
Journal of Obesity & Metabolic Syndrome|March 24, 2020
Beta-Cell Function, Self-rated Health, and Lifestyle Habits in 64-Year-Old Swedish Women with Metabolically Healthy Obesity PhenotypeOla Hjelmgren, Anders Gummesson, Göran Bergström, et al.
Atherosclerosis|December 15, 2023
The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteinsElias Björnson, Martin Adiels, Göran Bergström, et al.
Cellular & Molecular Biology Letters|July 22, 2008
Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissuePer-Arne Svensson, Britt G Gabrielsson, Margareta Jernås, et al.
Nature Communications|May 4, 2021
Next generation plasma proteome profiling to monitor health and diseaseWen Zhong, Fredrik Edfors, Anders Gummesson, et al.
Clinical Drug Investigation|October 2, 2014
Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjectsAnders Gummesson, Haiyan Li, Michael Gillen, et al.
Scientific Reports|September 27, 2024
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidomeElias Björnson, Dimitrios Samaras, Malin Levin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2025
Thigh Muscles and Metabolic Dysfunction-Associated Steatotic Liver Disease: Findings From the SCAPIS/IGT-Microbiota StudyAmar Osmancevic, Anders Gummesson, Matthew Allison, et al.
European Journal of Preventive Cardiology|March 28, 2024
Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular diseasePatrick Royer, Elias Björnson, Martin Adiels, et al.
Journal of the American Heart Association|March 21, 2025
Resource Efficient Screening for Primary Prevention of Coronary Heart Disease: A Proof-of-Concept Test in the MESA CohortEva Hagberg, Elias Björnson, Martin Adiels, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|April 19, 2017
Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetesAnders Gummesson, Elisabeth Nyman, Mikael Knutsson, et al.
Journal of Obesity & Metabolic Syndrome|March 24, 2020
Beta-Cell Function, Self-rated Health, and Lifestyle Habits in 64-Year-Old Swedish Women with Metabolically Healthy Obesity PhenotypeOla Hjelmgren, Anders Gummesson, Göran Bergström, et al.
Atherosclerosis|December 15, 2023
The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteinsElias Björnson, Martin Adiels, Göran Bergström, et al.
Cellular & Molecular Biology Letters|July 22, 2008
Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissuePer-Arne Svensson, Britt G Gabrielsson, Margareta Jernås, et al.
Nature Communications|May 4, 2021
Next generation plasma proteome profiling to monitor health and diseaseWen Zhong, Fredrik Edfors, Anders Gummesson, et al.
Clinical Drug Investigation|October 2, 2014
Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjectsAnders Gummesson, Haiyan Li, Michael Gillen, et al.
Scientific Reports|September 27, 2024
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidomeElias Björnson, Dimitrios Samaras, Malin Levin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 23, 2025
Thigh Muscles and Metabolic Dysfunction-Associated Steatotic Liver Disease: Findings From the SCAPIS/IGT-Microbiota StudyAmar Osmancevic, Anders Gummesson, Matthew Allison, et al.
European Journal of Preventive Cardiology|March 28, 2024
Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular diseasePatrick Royer, Elias Björnson, Martin Adiels, et al.
Journal of the American Heart Association|March 21, 2025
Resource Efficient Screening for Primary Prevention of Coronary Heart Disease: A Proof-of-Concept Test in the MESA CohortEva Hagberg, Elias Björnson, Martin Adiels, et al.
Pageof 7